TABLE OF CONTENTS
Volume 44, Issue 9 (November (1) 2009)
Review
Second hematopoietic SCT for lymphoma patients who relapse after autotransplantation: another autograft or switch to allograft? FREE
C O Freytes and H M Lazarus
Bone Marrow Transplant 44: 559-569; advance online publication, August 24, 2009; doi:10.1038/bmt.2009.214
Original Articles
Tissue Typing
HLA matching affects clinical outcome of adult patients undergoing haematopoietic SCT from unrelated donors: a study from the Gruppo Italiano Trapianto di Midollo Osseo and Italian Bone Marrow Donor Registry
R Crocchiolo, F Ciceri, K Fleischhauer, R Oneto, B Bruno, S Pollichieni, N Sacchi, M P Sormani, R Fanin, G Bandini, F Bonifazi, A Bosi, A Rambaldi, P E Alessandrino, M Falda and A Bacigalupo
Bone Marrow Transplant 44: 571-577; advance online publication, April 13, 2009; doi:10.1038/bmt.2009.67
Conditioning Regimens
Reduced intensity versus full myeloablative stem cell transplant for advanced CLL
E Peres, T Braun, O Krijanovski, Y Khaled, J E Levine, G Yanik, K Kato and S Mineishi
Bone Marrow Transplant 44: 579-583; advance online publication, March 23, 2009; doi:10.1038/bmt.2009.61
Allografting
Non-intensive treatment with low-dose 5-aza-2'-deoxycytidine (DAC) prior to allogeneic blood SCT of older MDS/AML patients
M Lübbert, H Bertz, B Rüter, R Marks, R Claus, R Wäsch and J Finke
Bone Marrow Transplant 44: 585-588; advance online publication, April 13, 2009; doi:10.1038/bmt.2009.64
Outcome after allogeneic transplantation for adult acute myeloid leukemia patients exhibiting isolated or associated trisomy 8 chromosomal abnormality: a survey on behalf of the ALWP of the EBMT
P Chevallier, M Labopin, A Nagler, P Ljungman, L F Verdonck, L Volin, A R Zander, J Finke, G Socie, C Cordonnier, J-L Harousseau, M Mohty and V Rocha on behalf of the Acute Leukemia Working Party of the EBMT
Bone Marrow Transplant 44: 589-594; advance online publication, April 6, 2009; doi:10.1038/bmt.2009.68
Post-Transplant Events
Impact of PCR-based diagnosis of invasive pulmonary aspergillosis on clinical outcome
E Hardak, M Yigla, I Avivi, O Fruchter, H Sprecher and I Oren
Bone Marrow Transplant 44: 595-599; advance online publication, March 23, 2009; doi:10.1038/bmt.2009.65
Graft-versus-Tumor Effects
Characteristics and risk factors of oral mucositis after allogeneic stem cell transplantation with FLU/MEL conditioning regimen in context with BU/CY2
S Vokurka, K Steinerova, M Karas and V Koza
Bone Marrow Transplant 44: 601-605; advance online publication, April 6, 2009; doi:10.1038/bmt.2009.66
Psychosocial Study
Ethical reasoning about patient eligibility in allogeneic BMT based on psychosocial criteria
L W Foster, L McLellan, L Rybicki, T Tyler and B J Bolwell
Bone Marrow Transplant 44: 607-612; advance online publication, March 23, 2009; doi:10.1038/bmt.2009.58
Letters to the Editor
Factors predicting allogeneic PBSCs yield after G-CSF treatment in healthy donors
E Brissot, P Chevallier, T Guillaume, J Delaunay, S Ayari, V Dubruille, S Le Gouill, B Mahe, T Gastinne, N Blin, B Saulquin, G Flandrois, A Devys, V Stocco, A Cesbron, F Dehaut, P Moreau, J-L Harousseau and M Mohty
Bone Marrow Transplant 44: 613-615; advance online publication, March 23, 2009; doi:10.1038/bmt.2009.60
Successful engraftment of cord blood following a one-day reduced-intensity conditioning regimen in two patients suffering primary graft failure and sepsis
I Shimizu, H Kobayashi, K Nasu, F Otsuki, T Ueki, M Sumi, M Ueno, N Ichikawa and S Nakao
Bone Marrow Transplant 44: 617-618; advance online publication, April 6, 2009; doi:10.1038/bmt.2009.69
